IQVIA™ Real-World Insights Bibliography

Access to palivizumab against respiratory syncytial virus among high-risk children in English hospitals
Author(s): Zylbersztejn A, Standing J, De Stavola B, Hardelid P
Affiliations(s): IQVIA
Publication(s): 
Document Type(s): Abstract, Poster,
Countries: UK,
C:
Y:
Respiratory disease,
2019
  L:
A:
English
  Add to report
 
 
Access to palivizumab against respiratory syncytial virus among high-risk children in English hospitals
Author(s): Zylbersztejn A, Standing J, De Stavola B, Hardelid P
Affiliations(s): 
Publication(s): 
Document Type(s): Oral communication,
Countries: UK,
C:
Y:
Respiratory disease,
2019
  L:
A:
English
  Add to report
 
 
Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe
Author(s): Fife D, Waller J, Kaplan S, Hu P, Phillips S, Oliveria SA, Richarz U
Affiliations(s): Fife: Janssen Research and Development, LLC Waller: Adephi Real World Kaplan: Teva Pharmaceutical Indusries Ltd. Hu: Janssen Global Services Phillips: IQVIA Oliveria, IQVIA Richarz: Janssen Research and Development, LLC
Publication(s):  Clin Drug Investig (2019). https://doi.org/10.1007/s40261-019-00831-3
Document Type(s): Article,
Countries: Belgium, France, Germany, Spain, UK,
Click here for the abstract
C:
Y:
Drug safety, Drug Utlization Study,
2019
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
European Multi-Country Drug Utilization Study of Dulaglutide
Author(s): Ayad K. Ali1, Karen E. Wells2, Mathieu Ros?3, Massoud Toussi3
Affiliations(s): 1Eli Lilly and Company, Indianapolis, IN, USA 2IQVIA, Oakland, MI, USA 3IQVIA, Courbevoie, France
Publication(s):  ICPE, Philadelphia, USA, 24-28 August 2019
Document Type(s): Abstract,
Countries: France, Germany, Spain, Sweden, UK,
C:
Y:
Diabetes, Drug safety,
2019
  L:
A:
English
Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
Use of maximum medical therapy in primary open-angle glaucoma: a retrospective, electronic medical records-based study from the UK
Author(s): Costa VP1, Durus A2, Gondos A3, Bezlyak V2, Wintermantel T3, Sagkriotis A2, Hubatsch D4, Kim YS2
Affiliations(s): 1: Department of Ophthalmology, University of Campinas, Sao Paulo, Brazil; 2: Novartis Pharma AG, Basel, Switzerland; 3: Real World Insights, IQVIA, Basel, Switzerland; 4: Novartis Pharmaceutical Corporation Inc, Fort Worth, TX, USA
Publication(s):  Wolrd Glaucoma Congress, Melbourne, Australia, 27-30 March 2019
Document Type(s): Poster,
Countries: UK,
C:
Y:
Ophthalmology,
2019
  L:
A:
English
clinical setting: Secondary care, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Association between changes in anatomical and functional outcomes and physicians? decisions to treat patients with licensed anti-VEGFs for neovascular age-related macular degeneration in the UK
Author(s): Chakravarthy U1, Kap E2, Pillai N2, Syntosi A3, Sagkriotis A3
Affiliations(s): 1. Centre for Experimental Medicine, Institute of Clinical Science, Queen's University Belfast, Belfast, UK; 2. IQVIA, Switzerland, Germany; 3. Novartis Pharma AG, Basel, Switzerland
Publication(s):  19th EURETINA Congress, Paris, France, 5-8 September 2019
Document Type(s): Oral presentation,
Countries: UK,
C:
Y:
Ophthalmology,
2019
  L:
A:
English
clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis,
  Add to report
 
 
Drug utilization and associated visual acuity in patients treated with anti-VEGFs for neovascular age-related macular degeneration (nAMD) in the UK
Author(s): Sagkriotis A1, Bennett N2, Skelly A1, Venkatesan S3, Oyetunde S2
Affiliations(s): 1. Novartis Pharma AG, Basel, Switzerland; 2. Novartis Pharmaceuticals UK Limited, Surrey, United Kingdom; 3. IQVIA Real World Insights, UK
Publication(s):  19th EURETINA Congress, Paris, France, 5-8 September 2019
Document Type(s): Poster,
Countries: UK,
C:
Y:
Ophthalmology,
2019
  L:
A:
English
clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis,
  Add to report
 
 
European survey on stable angina: real world insights on patients' characteristics, perception of disease, and quality of life
Author(s): Heiman F1, Peduto I1, Pegoraro V1, Cipelli R1, Ambrosio G2, Camm AJ3, Collins P4, Dechend R5, Lopez-Sendon J6, Manolis AJ7
Affiliations(s): 1 IQVIA, Milan, Italy 2 Division of Cardiology, University of Perugia School of Medicine, Perugia, Italy 3 Imperial College London, London, United Kingdom - Cardiology Clinical Academic Group, Molecular & Clinical Sciences Institute, St. George?s University of London, London, United Kingdom 4 National Heart and Lung Institute, Imperial College London, United Kingdom - Royal Brompton Hospital, London, United Kingdom 5 Experimental and Clinical Research Center, A joint cooperation between the Max-Delbruck Center for Molecular Medicine and the Charit? Medical Faculty, Berlin, Germany - HELIOS-Clinic, Berlin, Germany 6 Cardiology, Hospital Universitario La Paz, IdiPaz, Madrid, Spain 7 Department of Cardiology, Asklepeion General Hospital, Athens, Greece
Publication(s):  ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Type(s): Poster,
Countries: Germany, Italy, Spain, UK,
C:
Y:
Cardiovascular disease,
2019
  L:
A:
English
Survey research,
  Add to report
 
 
Adoption of immuno-oncology in NSCLC, a real-world study in EU5.
Author(s): Alejandra Martinez De Pinillos,?Isabel Ricote Lobera,?Cristina Martinez,?Caroline Anger,?Filippo Guglielmetti,?Roberto Jorge Bitton
Affiliations(s): IQVIA, London, United Kingdom; IQVIA, Madrid, Spain; IQVIA, Milan, Italy; IQVIA, Buenos Aires, Argentina
Publication(s):  Journal of Clinical Oncology?2019?37:15_suppl,?e20631-e20631
Document Type(s): Abstract,
Countries: France, Germany, Italy, Spain, UK,
Click here for the abstract
C:
Y:
Oncology,
2019
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
"Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice"
Author(s): "Marcello Arca, David Ansell , Maurizio Averna, Francesca Fanelli, Katherine Gorcyca, Serban R. Iorga, Aldo P. Maggioni, Georges Paizis, Radovan Tomic, Alberico L. Catapano"
Affiliations(s): Sanofi
Publication(s): 
Document Type(s): Article,
Countries: UK,
C:
Y:
Cardiovascular disease,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
 1 of 101 Next Page Last Page